3 results
The primary objective of this efficacy and safety study is to demonstrate that tight control of disease activity using stringent criteria based on CDAI, hs-CRP, fecal Calprotectin, and corticosteroid use improves the rate of mucosal healing 48 weeks…
Primary Objectives: * to establish - which is the best treatment, MTX or baricitinib, to ensure rapid symptom relief of recent onset UA, based on clinical and patient reported outcomes from baseline to 3 months. Secondary Objective: * to establish…
The objectives of this study are:1) Assessing the user-friendliness of a self-sampling technique.2) Assessing the quality of the self-collected sample (volume and composition).3) To estimate the degree of agreement between viral loads in the self-…